Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma
ALGAZI, A. P, WEBER, J. S, DAUD, A. I, ANDREWS, S. C, URBAS, P, MUNSTER, P. N, DECONTI, R. C, HWANG, J, SONDAK, V. K, MESSINA, J. L, MCCALMONT, T
Published in British journal of cancer (03.01.2012)
Published in British journal of cancer (03.01.2012)
Get full text
Journal Article
Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma
DECONTI, R. C, ALGAZI, A. P, DAUD, Al, ANDREWS, S, URBAS, P, BORN, O, STOECKIGT, D, FLOREN, L, HWANG, J, WEBER, J, SONDAK, V. K
Published in British journal of cancer (09.11.2010)
Published in British journal of cancer (09.11.2010)
Get full text
Journal Article
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma
Daud, A. I, Xu, C, Hwu, W.-J, Urbas, P, Andrews, S, Papadopoulos, N. E, Floren, L. C, Yver, A, DeConti, R. C, Sondak, V. K
Published in Cancer chemotherapy and pharmacology (01.03.2011)
Published in Cancer chemotherapy and pharmacology (01.03.2011)
Get full text
Journal Article
A phase I/II trial of DTIC and dasatinib in metastatic melanoma
Algazi, A. P., Weber, J. S., Andrews, S., Urbas, P., Arimura, E., Hwang, J., Sondak, V. K., Bastian, B., Daud, A.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Phase II trial of extended dose anti-CTLA-4 antibody ipilimumab (formerly MDX-010) with a multipeptide vaccine for resected stages IIIC and IV melanoma
Weber, J. S., Sarnaik, A., Targan, S., Yu, B., Morelli, D., Urbas, P., Maker, N., Yellin, M., Nichol, G.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Phase II Trial of Karenitecin in Patients with Malignant Melanoma: Clinical and Translational Study
DAUD, Adil, VALKOV, Nikola, HAUSHEER, Frederick, SULLIVAN, Daniel, CENTENO, Barbara, DERDERIAN, Jennifer, SULLIVAN, Patricia, MUNSTER, Pamela, URBAS, Patricia, DECONTI, Ronald C, BERGHORN, Elmer, ZHENMEI LIU
Published in Clinical cancer research (15.04.2005)
Published in Clinical cancer research (15.04.2005)
Get full text
Journal Article
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon [alpha]-2b in patients with resected high-risk melanoma
Daud, A I, Xu, C, Hwu, W-j, Urbas, P, Andrews, S, Papadopoulos, N E, Floren, L C, Yver, A, Deconti, R C, Sondak, V K
Published in Cancer chemotherapy and pharmacology (01.03.2011)
Published in Cancer chemotherapy and pharmacology (01.03.2011)
Get full text
Journal Article
Phase II trial of sagopilone (ZK-EPO), a novel epothilone, in patients with metastatic melanoma
Wenk, D., DeConti, R. C., Urbas, P., Andrews, S., Sondak, V. K., Maker, N., Weber, J. S., Daud, A. I.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
340 POSTER Gene therapy with plasmid IL-12 delivered by electroporation in patients with malignant melanoma: results of first human Phase I trial
Heller, R., DeConti, R., Messina, J., Andrews, S., Urbas, P., Ugen, K., Puleo, C., Sondak, V., Riker, A., Daud, A.
Published in European journal of cancer supplements (01.11.2006)
Published in European journal of cancer supplements (01.11.2006)
Get full text
Journal Article